Low Knockout Efficiency in Primary and Stem Cells? Constitutive CRISPR Knockout with Lentiviral Vectors

Constitutive CRISPR single-gene knockout using lentiviral vectors is a well-established and effective tool for gene-editing research. By combining the CRISPR/Cas9 editing system with lentiviral delivery, this approach enables stable and sustained knockout of target genes across a broad range of cell types. It is widely used in functional genomics, disease mechanism research, and drug target validation, providing a reliable platform for generating stable gene-edited cell models.

Conventional chemical transfection can be inefficient in hard-to-transfect cell types such as primary cells, stem cells, and neurons. In addition, transient expression of exogenous editing components may not provide sufficient duration for stable gene knockout. Miaoling’s plasmid platform uses a constitutive CRISPR knockout system delivered by lentiviral vectors, leveraging the stable integration properties of lentiviral systems to support long-term gene editing and the generation of stable knockout cell lines.

Mechanism and Key Advantages

1. Mechanism of Action

The constitutive lentiviral single-gene knockout system integrates the sgRNA and Cas9 nuclease expression cassettes into a lentiviral vector. Following lentiviral transduction, the CRISPR/Cas9 components are delivered into the target cells.

Once expressed, the sgRNA is transcribed under the control of the U6 promoter, while Cas9 is expressed from a constitutive promoter such as CMV or EF1α. The sgRNA guides Cas9 to the target genomic locus, where Cas9 generates a site-specific double-strand DNA break. The resulting break is primarily repaired through non-homologous end joining (NHEJ), which can introduce insertions or deletions (indels) that disrupt the target gene.

2.Key Advantages

① Broad Cell-Type Compatibility

Lentiviral vectors can efficiently transduce cell types that are often difficult to transfect using lipid-based methods, including primary cells, stem cells, immune cells, and neurons. This expands the range of cell models suitable for CRISPR-based gene editing.

② Stable, Long-Term Editing

Lentiviral vector sequences can integrate into the host-cell genome, allowing the CRISPR components to be maintained through cell division. This supports long-term gene-editing studies, extended cell culture, and longitudinal functional analyses.

③ Integrated Vector Design Simplifies Selection

Integrated vectors can incorporate fluorescent reporters and antibiotic-resistance markers, allowing researchers to monitor transduction and enrich for successfully transduced cells. This can simplify the workflow compared with approaches that require multiple plasmids to be introduced separately.

Core Components of Lentiviral CRISPR Knockout Vectors

A typical all-in-one knockout vector contains five key functional elements that work together to support gene editing and selection of positive cells:

U6 Promoter:

 Drives efficient transcription of the sgRNA to provide sufficient guide RNA for target recognition.

Constitutive Promoter (CMV/EF1α):

Drives continuous expression of the Cas9 nuclease to support sustained editing activity.

Antibiotic-Resistance Marker:

Markers such as puromycin resistance (Puro) and neomycin resistance (Neo) enable antibiotic-based selection of transduced cells.

Fluorescent Reporter:

Fluorescent proteins such as EGFP and mCherry provide a convenient way to monitor transduction and identify fluorescent-positive cells.

Multiple Cloning Site (MCS):

Provides a cloning region for inserting gene-specific sgRNA sequences targeting different genes.

Lentiviral CRISPR Knockout Vectors from Miaoling

Miaoling offers a range of established all-in-one lentiviral CRISPR knockout vectors designed to accommodate different requirements for fluorescent reporters, selection markers, and experimental configurations.

1.pLV3-U6-MCS-sgRNA1-sgRNA2-Cas9-EGFP-Puro

Catalog No.: P88193

Built on a third-generation self-inactivating lentiviral backbone, this vector supports expression of two sgRNAs from a single plasmid and incorporates an EGFP fluorescent reporter and puromycin resistance marker. It can be used for multiplex gene-editing applications requiring dual sgRNA expression.

2.pLentiCRISPRV2 Classic Series

pLentiCRISPRV2 (Catalog No. P0114):

A widely used CRISPR lentiviral backbone featuring puromycin selection for a broad range of gene-knockout applications.

pLentiCRISPRV2-Neo (Catalog No. P7901):

Features a G418/neomycin-resistance marker, making it suitable for cell lines that already carry puromycin resistance or require an alternative selection marker.

3.pLV3 Third-Generation Lentiviral Knockout Series

Based on a third-generation self-inactivating lentiviral backbone, the pLV3 series is designed for applications requiring an integrated lentiviral CRISPR knockout system.

pLV3-U6-MCS-sgRNA-Cas9-EGFP-Puro (Catalog No. P44008):

An EGFP-labeled all-in-one vector designed for general CRISPR knockout applications.

pLV3-U6-MCS-sgRNA-Cas9-mCherry-Puro (Catalog No. P44551):

Features an mCherry fluorescent reporter and is suitable for experiments involving multicolor fluorescence analysis or flow cytometry-based detection.

Supporting Services

Miaoling’s plasmid platform also provides one-stop sgRNA knockout lentivirus packaging services, including single-target knockout lentivirus, multiplex targeting options, and negative-control lentivirus.

The service covers standardized vector packaging, concentration and purification, and viral titer quality control, providing ready-to-use lentiviral preparations without requiring laboratories to establish and optimize their own viral packaging workflow.

Common Experimental Challenges and Potential Solutions

Low Target-Gene Knockout Efficiency

Potential approaches:

• Redesign and screen for a more specific and effective sgRNA.
• Optimize viral titer and determine an appropriate MOI.
• Optimize the duration of antibiotic selection.

Significant Off-Target Editing

Potential approaches:

• Select sgRNAs with improved predicted specificity.
• Consider dual-sgRNA strategies for coordinated targeting.
• Consider high-fidelity Cas9 variants to reduce potential off-target activity.

Extensive Cell Death After Lentiviral Transduction

Potential approaches:

• Reduce the viral dose or MOI.
• Optimize the virus–cell exposure period.
• Consider an inducible CRISPR system as an alternative to constitutive expression when prolonged Cas9 activity may affect cell viability.

Generating Cell Lines with Multiple Gene Knockouts

Potential approaches:

• Perform sequential transduction using lentiviral vectors carrying different sgRNAs.
• Use a multiplex vector containing tandem sgRNA expression cassettes for simultaneous targeting of multiple genes.

 

https://www.miaolingbio.net
Wuhan MiaoLing Biotechnology Co., Ltd.